Clinical Trial Update: Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine

View source ↗

Summary

This is a completed post-marketing safety study of GlaxoSmithKline's Pediarix vaccine, a DTaP-HepB-IPV combination, evaluating safety for Hepatitis B, Poliomyel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Hepatitis B
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• Pediarix (DTaP-HepB-IPV combination vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Poliomyelitis | Status: COMPLETED